ストックスクリーナーアプリを入手
149.32
0.50%
-0.22
前日終値:
$149.54
開ける：
$149.77
24時間の取引高:
147.92K
Relative Volume:
0.05
時価総額：
$31.85B
収益：
$447.02M
当期純損益:
$-1.18B
株価収益率:
-24.16
EPS:
-6.1812
ネットキャッシュフロー:
$-906.14M
1週間 パフォーマンス:
-5.33%
1か月 パフォーマンス:
-15.45%
6か月 パフォーマンス:
+35.81%
1年 パフォーマンス:
+90.46%
1日の値動き範囲:
$148.41
$150.57
1週間の範囲:
$146.40
$157.90
52週間の値動き範囲:
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
Compare INSM vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
149.35 | 31.89B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.81 | 119.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
769.28 | 82.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
843.37 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
323.00 | 42.28B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
357.30 | 38.60B | 4.98B | 69.60M | 525.67M | 0.5198 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-28 | 開始されました | Barclays | Overweight |
| 2026-01-23 | 開始されました | Roth Capital | Buy |
| 2025-12-19 | 再開されました | Truist | Buy |
| 2025-12-04 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-28 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 開始されました | Wells Fargo | Overweight |
| 2025-08-20 | 開始されました | William Blair | Outperform |
| 2025-08-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 開始されました | Jefferies | Buy |
| 2025-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-04-23 | 開始されました | Truist | Buy |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-07-26 | 開始されました | Guggenheim | Buy |
| 2022-12-09 | 開始されました | Mizuho | Buy |
| 2022-12-07 | 開始されました | Barclays | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Buy |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2021-12-06 | 開始されました | JP Morgan | Overweight |
| 2021-10-19 | 再開されました | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-10-12 | 再開されました | Stifel | Buy |
| 2019-09-03 | 開始されました | Goldman | Buy |
| 2019-04-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-15 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | アップグレード | Goldman | Neutral → Buy |
| 2019-01-02 | 開始されました | Canaccord Genuity | Buy |
| 2018-08-06 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 開始されました | Goldman | Neutral |
| 2018-04-23 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 開始されました | Morgan Stanley | Overweight |
| 2018-01-18 | 開始されました | Credit Suisse | Neutral |
| 2017-09-05 | 繰り返されました | Evercore ISI | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-11 | 開始されました | Robert W. Baird | Outperform |
| 2016-03-15 | 開始されました | Stifel | Buy |
| 2015-11-09 | ダウングレード | UBS | Buy → Neutral |
| 2015-10-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-06-09 | 開始されました | Citigroup | Neutral |
| 2014-03-26 | 繰り返されました | HC Wainwright | Buy |
すべてを表示
Insmed Inc (INSM) 最新ニュース
Essex Investment Management Co. LLC Grows Stake in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Envestnet Asset Management Inc. - MarketBeat
When Will Insmed Incorporated (NASDAQ:INSM) Become Profitable? - Yahoo Finance
Insmed, Inc. $INSM Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Insider Sell: Martina Flammer Sells Shares of Insmed Inc (INSM) - GuruFocus
Valuation Update: Is Insmed Incorporated stock a buy or sell2025 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn
Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026 - Financial Times
C WorldWide Group Holding A S Sells 75,000 Shares of Insmed, Inc. $INSM - MarketBeat
Truist Financial Corp Sells 7,420 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Stock Holdings Lessened by WCM Investment Management LLC - MarketBeat
Insmed Presents Data on TPIP Inhalation Drug for PAH - respiratory-therapy.com
MACD Signal: What are the risks of holding Insmed Incorporated2025 Retail Activity & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Principal Financial Group Inc. Has $124.47 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Keybank National Association OH Has $2.41 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Mid-Cap Biopharmas Flex Their Commercial Muscle - Citeline News & Insights
Whale Trades: What are the risks of holding Insmed IncorporatedMarket Movement Recap & Capital Efficiency Focused Strategies - baoquankhu1.vn
Y Intercept Hong Kong Ltd Decreases Position in Insmed, Inc. $INSM - MarketBeat
Rate Cut: Will Insmed Incorporated outperform its industry peers2025 Trading Volume Trends & Low Drawdown Trading Techniques - baoquankhu1.vn
Bank of New York Mellon Corp Trims Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed (INSM) Sees Surge in Bullish Option Activity - GuruFocus
Morgan Stanley Updates Rating for Insmed (INSM), Adjusts Price T - GuruFocus
New York State Common Retirement Fund Buys 18,123 Shares of Insmed, Inc. $INSM - MarketBeat
Federated Hermes Inc. Acquires 219,838 Shares of Insmed, Inc. $INSM - MarketBeat
What Insmed (INSM)'s Upcoming TPIP Data and New Analyst Coverage Mean For Shareholders - Yahoo Finance
Insmed TPIP Data At PVRI 2026 Tests Pulmonary Arterial Hypertension Ambitions - Yahoo Finance
Insmed (NASDAQ:INSM) Coverage Initiated at Barclays - MarketBeat
Definium Therapeutics Appoints Roger Adsett To Board - citybiz
Definium Therapeutics Appoints Roger Adsett to Board of Directors, Effective from January 29, 2025 - marketscreener.com
J. Safra Sarasin Holding AG Invests $1.09 Million in Insmed, Inc. $INSM - MarketBeat
Definium Therapeutics Appoints Roger Adsett to Board of Directors - Business Wire
Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed - Barchart.com
Barclays Initiates Coverage on Insmed With Overweight Rating, $231 Price Target - marketscreener.com
Barclays Initiates Coverage on Insmed (INSM) with Overweight Rat - GuruFocus
Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress - PR Newswire
EFG Asset Management North America Corp. Reduces Stake in Insmed, Inc. $INSM - MarketBeat
Mutual of America Capital Management LLC Lowers Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Strs Ohio Grows Stake in Insmed, Inc. $INSM - MarketBeat
Does Insmed Incorporated have strong fundamentalsJuly 2025 News Drivers & AI Based Buy and Sell Signals - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Trims Stake in Insmed, Inc. $INSM - MarketBeat
Insmed Incorporated (INSM) Stock Analysis: Potential 37% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
Setup Watch: What is ROIVs book value per shareWall Street Watch & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Insmed, Inc. $INSM Stock Holdings Lessened by Emerald Mutual Fund Advisers Trust - MarketBeat
Roth Capital Initiates Coverage of Insmed (INSM) with Buy Recommendation - Nasdaq
Stifel Initiates Insmed(INSM.US) With Buy Rating, Announces Target Price $212 - 富途资讯
Roth Capital Initiates Coverage on Insmed (INSM) with Buy Rating - GuruFocus
Roth/MKM initiates Insmed stock with Buy rating, $212 price target - Investing.com Canada
Insmed (INSM) chair and CEO Lewis sells $1.7M in stock By Investing.com - Investing.com Nigeria
Insmed (INSM) chair and CEO Lewis sells $1.7M in stock - Investing.com
Insider Selling: Insmed (NASDAQ:INSM) CEO Sells 10,699 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed IncorporatedINSM - PR Newswire
Breaking Down Insmed: 18 Analysts Share Their Views - Benzinga
Insmed Inc (INSM) 財務データ
収益
当期純利益
現金流量
EPS
Insmed Inc (INSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Flammer Martina M.D. | Chief Medical Officer |
Feb 05 '26 |
Sale |
152.44 |
869 |
132,470 |
83,243 |
0.12%
6.09%
大文字化:
|
ボリューム (24 時間):